Nuvation Bio Inc. is trading 13.4% up today at $5.35, extending momentum following management's participation in a fireside chat at the Jefferies Global Healthcare Conference.
- Investors are responding positively to the company’s updated business commentary and outlook shared during the presentation.
- The stock continues its upward trend from the previous session, with no new regulatory filings or specific macroeconomic catalysts reported for the company today.